Moleculin Biotech, Inc. (MBRX)
3.20
-0.12
(-3.61%)
USD |
NASDAQ |
Dec 31, 11:18
Moleculin Biotech EPS Diluted (Quarterly): -17.02 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Harvard Bioscience, Inc. | -0.0276 |
| Intensity Therapeutics, Inc. | -0.062 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.40M |
| Total Expenses (Quarterly) | 25.40M |
| Enterprise Value | 0.5594M |
| Earnings Yield | -1.37K% |
| Normalized Earnings Yield | -2517.01 |